Search results
Results from the WOW.Com Content Network
The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients with inoperable or metastatic triple-negative breast cancer versus the older and ...
The late-stage trial has been closely watched by investors and analysts who forecast that the drug, known as Dato-DXd, could potentially be another best-selling medicine for AstraZeneca. The drug ...
About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo. Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients ...
Drug coupons reduce out-of-pocket costs for consumers in a variety of ways such as instant savings offers, free trial offers (also known as try-before-you-buy offers), copay reduction or rebates. Generic drug companies rarely offer coupons, though insurance companies occasionally offer discounts on generic drugs.
It is being developed by AstraZeneca. [2] It is being investigated as a treatment for pancreatic cancer with a phase 1 trial (University of Michigan researchers are as of 2019 planning a phase 2 study. [3]), and ovarian cancer, in combination with another anti-cancer drug, gemcitabine, as a phase 2 trial. [4] [5] [6]
AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent ...
By Eva Mathews (Reuters) -AstraZeneca said on Friday its blockbuster cancer drug Imfinzi helped improve survival in patients in the early stages of an aggressive type of lung cancer, making it the ...
The trial, known as ADJUVANT BR.31 Phase III, sought to evaluate Imfinzi in the adjuvant treatment of 1,415 patients with an early stage of non-small-cell lung cancer following complete tumour ...